Made a couple of changes.. I'm trying to make the watchlist clearer, I'm using a 6 month chart which is a larger size than previously if you click into it, I'm trying to write 2 plans for each stock and obviously the ones I can't write a plan for shorting, is a straight up long, and vice versa. Please give me feedback of what you think.
NewLink Genetics Corporation (NLNK)
Short Plan: Gap Up over $50. Parabolic. Risk off $55. Sizing in from after $53.75.
Story: There's talk about some decision on a widespread Ebola vaccination. They also beat earning last Thursday and haven't had a pullback yet.
Thoughts: I think this would be a nice potential short, but you'd need to be able to risk $400 which is too much for me but if this does get up around $55 and pulls back $1-2 and you've sized in right, this could easily be a $600-$1,200 trade.
Ocular Therapeutix, Inc. (OCUL)
Short Plan: Gap Up over $40, Parabolic, Risk off $45.
Story: No news, other than them announcing that they will announce their earnings on March 10th.
Thoughts: Not really sure What's going on with this one.. The news seems irrelevant and There's just chatter on the message boards about how high it might go..
Chegg, Inc. (CHGG)
Long Plan: Weak Open down to $8.50, higher low, R/G
Short Plan: Gap Up, Parabolic through $9, Risk off $9.50
Story: No News
Thought: I think this is a continuation of the earnings move on February 23rd.. I think it just needed to consolidate a bit.
Ohr Pharmaceutical, Inc. (OHRP)
Long Plan: Weak Open down to $10.50, Higher Low or consolidation. Perk
Story:They announced positive data of some study on the 02-03-2015. This was obviously positive news and could keep running a for another day without a pullback.
Orexigen Therapeutics, Inc. (OREX)
Long Plan: Weak Open down to around $8, Higher Low
Story: Released Drug News when they weren't supposed to.
Thoughts: I think it could go another day before a pullback
Capnia, Inc. (CAPN)
Short Plan: Gap Up Over $9, Parabolic, Risk off $10
Story: No News, just a crappy Hot Biotech
Thoughts: Up 400% in 2-3weeks. Bias: Short Short Short
Fibrocell Science, Inc. (FCSC)
Short Plan: Gap Up, Parabolic through $6, Risk off $6.50
Story: No News, Just another Hot Pharmaceutical
Thoughts: Up 100% in 2 months but quite chopppy, who cares though.. I wouldn't be holding this to 0.
CorMedix, Inc. (CRMD)
Short Plan: Gap Up, Parabolic through $6.50, Risk off $7.
Story: Hot Biotech, nothing else
Thoughts: This is up 200% in the last 2 months.. Potential Short. Too Scary to long at these levels
Sky-mobi Limited (MOBI)
Long Plan: Weak Open, Higher Low, Breakout over $5.
Story: Announced Earnings on February 26th. It's also a Former Runner.
No comments:
Post a Comment